First-line chemotherapy for non-small-cell lung cancer: Is there a superior regimen based on histology?

被引：44
|
作者：
Einhorn, Lawrence H. [1 ]
机构：
[1] Indiana Univ, Dept Med, Div Hematol Oncol, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 21期
关键词：
D O I：
10.1200/JCO.2008.17.2056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3485 / 3486
页数：2
相关论文
共 50 条
  • [1] Non-small-cell lung cancer progression after first-line chemotherapy.
    Lara Jr. P.N.
    Lau D.H.
    Gandara D.R.
    Current Treatment Options in Oncology, 2002, 3 (1) : 53 - 58
  • [2] First-Line Immunotherapy for Non-Small-Cell Lung Cancer
    Reck, Martin
    Remon, Jordi
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 586 - +
  • [3] Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer
    Hayashi, H.
    Okamoto, I.
    Morita, S.
    Taguri, M.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1537 - 1541
  • [4] Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer
    Kaderbhai, Coureche-Guillaume
    Richard, Corentin
    Fumet, Jean David
    Aarnink, Anne
    Ortiz-Cuaran, Sandra
    Perol, Maurice
    Foucher, Pascal
    Coudert, Bruno
    Favier, Laure
    Lagrange, Aurelie
    Limagne, Emeric
    Boidot, Romain
    Ladoire, Sylvain
    Poudenx, Michel
    Ilie, Marius
    Hofman, Paul
    Saintigny, Pierre
    Ghiringhelli, Francois
    ONCOIMMUNOLOGY, 2017, 6 (09):
  • [5] First-line treatment for advanced non-small-cell lung cancer
    Laskin, Janessa J.
    Sandler, Alan B.
    ONCOLOGY-NEW YORK, 2005, 19 (13): : 1671 - 1676
  • [6] First-line immunotherapy in advanced non-small-cell lung cancer
    Noronha, Vanita
    Mehta, Prashant
    Malik, Prabhat Singh
    Patel, Amol
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2019, 40 (04) : 461 - 462
  • [7] Erlotinib in the first-line treatment of non-small-cell lung cancer
    D'Arcangelo, Manolo
    Cappuzzo, Federico
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 523 - 533
  • [8] Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer
    Reck, Martin
    IMMUNOTHERAPY, 2018, 10 (02) : 93 - 105
  • [9] Oxaliplatin in First-line Therapy for Advanced Non-Small-Cell Lung Cancer
    Raez, Luis E.
    Kobina, Svetlana
    Santos, Edgardo S.
    CLINICAL LUNG CANCER, 2010, 11 (01) : 18 - 24
  • [10] Beyond Doublet Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Combination of Targeted Agents with First-Line Chemotherapy
    Herbst, Roy S.
    Lynch, Thomas J.
    Sandler, Alan B.
    CLINICAL LUNG CANCER, 2009, 10 (01) : 20 - 27
12345